Ildong Pharmaceutical and Ildong Holdings Hold Regular Shareholders' Meetings

Strengthening Core Competencies and Creating Future Growth Engines

Ildong Pharmaceutical and Ildong Holdings announced that they each held their regular shareholders' meetings on the 26th at the headquarters of Ildong Pharmaceutical in Seocho-gu, Seoul.

At the 10th regular shareholders' meeting of Ildong Pharmaceutical, all agenda items presented—including the approval of financial statements, partial amendments to the articles of incorporation, and the appointment of directors and auditors—were passed as originally proposed. This year, as part of expanding shareholder returns, the company plans to pay a reduced dividend of 200 won (tax-free) per share.

Yoon Woongseop, CEO of Ildong Pharmaceutical, is speaking at the regular shareholders' meeting held on the 26th at the Ildong Pharmaceutical headquarters in Seocho-gu, Seoul. Ildong Pharmaceutical

Yoon Woong-seop, CEO of Ildong Pharmaceutical, stated during his greeting, "This year, under our management policy of 'achieving a competitive edge in performance,' we will focus on strengthening the fundamentals of our core businesses such as pharmaceuticals, as well as creating future growth engines through R&D and other initiatives. Our efforts will be directed toward generating sales and profit results, securing new growth drivers, and establishing a sustainable business system."

Similarly, at the 83rd regular shareholders' meeting of Ildong Holdings, all agenda items—including the approval of financial statements reflecting the dividend plan, partial amendments to the articles of incorporation, and the appointment of directors and auditors—were passed as originally proposed.

Park Dae-chang, CEO of Ildong Holdings, said, "We plan to continue promoting management efficiency and renewal within our group affiliates to strengthen our business foundation and lay the groundwork for growth, while also striving to enhance corporate value and increase shareholder interests."

This content was produced with the assistance of AI translation services.